...
首页> 外文期刊>癌と化学療法 >Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment
【24h】

Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment

机译:两例复发性乳腺癌伴局部淋巴结转移,显示对曲妥珠单抗和紫杉醇治疗有完全反应

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We report two cases of recurrent breast cancer with regional lymph node metastases that responded completely to treatment with trastuzumab and paclitaxel. Case 1: A 52-year-old woman, who presented with left breast cancer, underwent mastectomy and axillary lymph node dissection in July 2002. Pathological findings were as follows: invasive ductal carcinoma (scirrhous type), 2.2 cm in size, histological grade 3, positive invasion to the lymphatic and blood vessels, negative nodal status (0/11), negative ER/PgR status, and overexpression of HER 2eu. Left axillary lymph node metastasis was noted after five months, ie, in December 2002. Four cycles of chemotherapy with doxorubicin and cyclophosphamide were administered from January 2003; however, they were not effective. The patient showed a complete response after three months of chemotherapy with trastuzumab and paclitaxel. This treatment was stopped in September 2003. She has maintained a complete response for two and a half years and was not administered any further treatment as of February 2006. Case 2: A 59-year-old woman, who presented with right breast cancer, underwent mastectomy and axillary lymph node dissection in May 2002. Pathological findings were as follows: invasive ductal carcinoma (scirrhous type), 1.8 cm in size, histological grade 2, positive invasion to the lymphatic and blood vessels, negative nodal status (0/5), positive ER and uncertain PgR status, and overexpression of HER 2eu. She had received adjuvant hormonal therapy with tamoxifen; however, a right supraclavicular lymph node metastasis was noted in October 2004. Treatment with exemestane was not effective. However, a complete response was observed with trastuzumab and paclitaxel for four months. She has maintained a complete response for six months and was not administered any further treatment as of February 2006.
机译:我们报告了两例复发性乳腺癌,其局部淋巴结转移对曲妥珠单抗和紫杉醇的治疗完全反应。病例1:一名患有左乳腺癌的52岁女性,于2002年7月接受了乳房切除术和腋窝淋巴结清扫术。病理结果如下:浸润性导管癌(硬化型),大小2.2 cm,组织学分级3,淋巴和血管的阳性浸润,淋巴结状态(0/11),ER / PgR阴性,HER 2 / neu过表达。在五个月后,即2002年12月,注意到左腋窝淋巴结转移。从2003年1月开始,进行了四个周期的阿霉素和环磷酰胺化疗。但是,它们没有效果。曲妥珠单抗和紫杉醇化疗三个月后,患者显示出完全缓解。该治疗方法于2003年9月停止。她在两年半的时间里一直保持完全的反应,到2006年2月为止没有接受任何进一步的治疗。案例2:一名59岁的女性,患有右乳腺癌,于2002年5月进行了乳房切除术和腋窝淋巴结清扫术。病理结果如下:浸润性导管癌(硬化型),大小为1.8 cm,组织学等级为2,淋巴和血管阳性浸润,淋巴结阴性(0/5 ),阳性ER和不确定的PgR状态,以及HER 2 / neu的过度表达。她曾接受他莫昔芬的激素辅助治疗;然而,2004年10月发现右锁骨上淋巴结转移。依西美坦治疗无效。但是,曲妥珠单抗和紫杉醇在四个月内观察到完全缓解。她已经维持了六个月的完全缓解,并且自2006年2月起未接受任何进一步的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号